- Novo Nordisk invests $2.3 billion in France to boost obesity drug production Reuters
- Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site Yahoo Finance
- Macron to unveil 2.1-B euro Novo Nordisk pharma investment in France | ANC ANC 24/7
- Novo Nordisk responds to U.S. rival Eli Lilly by announcing new $2.3 billion investment in France to keep up with soaring demand for weight-loss drugs Fortune
- Novo Nordisk (NYSE:NVO) Pours $2.3B into Expanding Production in France – TipRanks.com TipRanks
- View Full Coverage on Google News
Read More: Novo Nordisk invests $2.3 billion in France to boost obesity drug production –